Filippo Petti is the founder of Celyad. Celyad has raised $33M in total funding. Backed by Fortress Investment Group. Based in Mont-Saint-Guibert, Belgium.
Filippo Petti is the CEO of Celyad Oncology, a clinical-stage biotechnology company located in Mont-Saint-Guibert, Belgium. The company focuses on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, utilizing a proprietary non-gene edited short hairpin RNA (shRNA) technology platform. Celyad Oncology recently secured a $32.5 million private placement from Fortress Investment Group in December 2021.
Full founder directory · Investor directory · Company funding database · Fundraising library